CLINICAL_TRIALS
trial_result
· 2024-02-05
Clinical Trial Update: Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus [Phase 1]
Summary
Phase 1 trial update for PF-07081532 in adults with type 2 diabetes mellitus has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2024-02-05